CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% |
| Q1 2021 | $46,323,000 | +2.4% | 49,064,000 | 0.0% | 0.97% | +8.9% |
| Q4 2020 | $45,236,000 | +2.5% | 49,064,000 | 0.0% | 0.89% | -16.8% |
| Q3 2020 | $44,114,000 | +0.2% | 49,064,000 | 0.0% | 1.07% | -16.2% |
| Q2 2020 | $44,037,000 | +1.0% | 49,064,000 | 0.0% | 1.28% | -7.3% |
| Q1 2020 | $43,581,000 | +1.6% | 49,064,000 | 0.0% | 1.38% | +1.0% |
| Q4 2019 | $42,905,000 | +1.5% | 49,064,000 | 0.0% | 1.37% | -20.5% |
| Q3 2019 | $42,262,000 | +165.8% | 49,064,000 | +172.6% | 1.72% | +201.8% |
| Q2 2019 | $15,902,000 | +242.2% | 18,000,000 | +260.0% | 0.57% | +220.8% |
| Q1 2019 | $4,647,000 | -72.6% | 5,000,000 | -69.7% | 0.18% | -74.5% |
| Q4 2016 | $16,979,000 | – | 16,500,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 69,346,000 | $107,321,000 | 3.81% |
| PFM Health Sciences, LP | 34,710,000 | $53,670,000 | 1.06% |
| Partner Investment Management, L.P. | 556,000 | $860,000 | 0.82% |
| Myriad Asset Management Ltd. | 5,000,000 | $7,731,000 | 0.75% |
| SYMPHONY ASSET MANAGEMENT LLC | 4,000,000 | $6,185,000 | 0.69% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $14,030,000 | 0.49% |
| CSS LLC/IL | 5,251,000 | $8,112,000 | 0.40% |
| SSI INVESTMENT MANAGEMENT LLC | 2,813,000 | $4,333,000 | 0.37% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,131,000 | $11,056,000 | 0.21% |
| D. E. Shaw & Co., Inc. | 27,750,000 | $42,835,000 | 0.07% |